SCHEMBL30926726

SCHEMBL30926726

O=C(Nc1ccccn1)c1cccc(NS(=O)(=O)c2ccc(Br)cc2)c1

nearest known ligand 0.70

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.62
▸ LMNA P02545 2/20 0.62
▸ ITGA1 P56199 1/20 0.62
▸ POLB P06746 1/20 0.61
▸ MEN1 O00255 6/20 0.58
▸ KMT2A Q03164 6/20 0.58
▸ ADORA3 P0DMS8 1/20 0.56
▸ SLC6A3 Q01959 1/20 0.56
▸ HPGD P15428 1/20 0.55
▸ RXFP1 Q9HBX9 1/20 0.53
▸ HSD17B2 P37059 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179771 1.00 ALDH1A1 (0.62) ALDH1A1LMNAITGA1POLBMEN1
SCHEMBL27180776 0.84 ALDH1A1 (0.60) ALDH1A1LMNAITGA1POLBMEN1
SCHEMBL30926434 0.84 ALDH1A1 (0.60) ALDH1A1LMNAITGA1POLBMEN1
SCHEMBL30926878 0.84 LMNA (0.82) ALDH1A1LMNAPOLBMEN1KMT2A
SCHEMBL27181000 0.84 LMNA (0.82) ALDH1A1LMNAPOLBMEN1KMT2A
SCHEMBL27179881 0.83 KMT2A (0.66) ALDH1A1LMNAITGA1MEN1KMT2A
SCHEMBL30926771 0.83 KMT2A (0.66) ALDH1A1LMNAITGA1MEN1KMT2A
SCHEMBL30926965 0.83 RXFP1 (0.56) ALDH1A1LMNAPOLBMEN1KMT2A
SCHEMBL27179671 0.83 RXFP1 (0.56) ALDH1A1LMNAPOLBMEN1KMT2A
SCHEMBL27180067 0.81 SMN1; SMN2 (0.66) ALDH1A1LMNAPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP ALDH1A1 1085/4885LMNA 4774/4885ITGA1 4848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback